Compare CORT & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | SUZ |
|---|---|---|
| Founded | 1998 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.8B |
| IPO Year | 2001 | 2002 |
| Metric | CORT | SUZ |
|---|---|---|
| Price | $111.91 | $7.86 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $96.50 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $13.28 |
| Revenue Next Year | $26.98 | $13.57 |
| P/E Ratio | $1,267.14 | ★ $5.58 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $7.56 |
| 52 Week High | $122.21 | $11.54 |
| Indicator | CORT | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 65.59 | 34.65 |
| Support Level | $76.41 | $7.56 |
| Resistance Level | $122.21 | $8.61 |
| Average True Range (ATR) | 5.21 | 0.18 |
| MACD | 0.55 | -0.05 |
| Stochastic Oscillator | 72.40 | 0.64 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.